MiniMed Group, Inc. Stock 12‑Month Price Target Raised to $25.71, Implies 37% Upside
Alpha Vantage · TradingView · · AI-summarised by FinFlash
Analysts have increased the 12-month average price target for MiniMed Group, Inc. stock to $25.71, up from $25.38, with individual forecasts ranging from $21 to $30 per share. This new target suggests a 37% potential upside from the Oct. 12 closing price. The consensus rating among 16 analysts remains a "Buy," with 12 recommending Buy, 3 Hold, and 1 Sell.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.